Behavior effects after LABP acute exposure. by Kassia Martins Fernandes Pereira (12219197)

“…<p><b>A.</b> The schematic of the behavioral testing after LABP exposure (20, 25, or 60 min) in different concentrations (1, 3, 100, 300, or 500 mg/L). …”

Expression of genes encoding proteins involved in protein folding, quality control, trafficking and ER-associated degradation differentially expressed in liver of <i>Fmo5</i><sup><... by Ian R. Phillips (5074121)

Effects of spatial management strategies (<i>s</i>) on the relative decrease in maximum metapopulation abundance in model networks when an obligate resource (K) is reduced in 50% o... by Miguel Lurgi (3144567)

A 50-year-old female patient with diffuse PTL. by Yu Xia (8822)

mRNA primers for real time PCR. by Laleh Pourmousavi (17675254)

Subjects:

Histological change in study groups. by Laleh Pourmousavi (17675254)

Subjects:

The comparison of serum levels of insulin in the study groups. by Laleh Pourmousavi (17675254)

Subjects:

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Placental gene expression at E9.5 and E11.5. by Hui Zhao (7395)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

The saturated fatty acid palmitate decreases viability and induces apoptosis in HUVECs. by Dustin M. Lee (8207457)

Scatterplot of fold-change expression for B-cell-specific mRNA transcripts in the whole blood. by Luísa Camacho (5508251)

“…The horizontal gray bars indicate a 2-fold increase and decrease in expression compared to control. …”

IC₅₀s data of antimalarials against controls. by Winnie Okore (14139712)

The oxygen level (kPa) for 50 and 100% habitat loss for each species and season under a doubling of atmospheric CO₂. by Emily Slesinger (6837740)

Increase in resistance grade is correlated with the loss of <i>in vitro</i> parasite infectivity and decreased cutaneous lesion size. by Jairo E. Perez-Franco (3166050)

Fig 3 - by Leila Vahdatiraad (17382718)

Decreased myofibroblasts in the peritumoral region and high expression of MMP-7 in Pan02 S.C. tumor of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)

“…Alcian blue staining (pH = 2.5) in the peritumoral region of Pan02 S.C. pancreatic tumors in <i>S100a4-Cre; Ext1</i>^<i>f/f</i> and control mice (middle). …”

Knockdown of factors in the 5′SS recognition complex U1 globally decreases intronic miRNA levels. by Maja M. Janas (200408)